ReviewInternational journal of molecular sciences2022

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment.

Lukas Wettstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.